documents: FDA-2003-N-0196-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2003-N-0196-0004 | FDA | FDA-2003-N-0196 | Table of Contents Time and Extent Application for Amiloxate - [Amiloxate, Neo Heliopan® 1000" - (Ego Pharmaceuticals, Pty Ltd. - Data and Information)] | Supporting & Related Material | BKG-Background Material | 2003-07-30T04:00:00Z | 2003 | 7 | 2010-07-16T16:00:52Z | 0 | 0 | 090000648048b559 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref